Xin Lang Cai Jing·2025-10-31 01:56Group 1 - The core point of the news is that Kailaiying's stock price dropped by 5.2% to 97.20 CNY per share, with a trading volume of 260 million CNY and a turnover rate of 0.84%, resulting in a total market capitalization of 35.05 billion CNY [1] - Kailaiying Pharmaceutical Group (Tianjin) Co., Ltd. is located in Tianjin Economic and Technological Development Zone and was established on October 7, 1998, with its listing date on November 18, 2016 [1] - The company's main business involves providing CMO pharmaceutical outsourcing services, with revenue composition being 76.19% from small molecule CDMO solutions, 23.71% from emerging services, and 0.10% from other sources [1] Group 2 - From the perspective of fund holdings, Guotou Ruijin Fund has one fund heavily invested in Kailaiying, specifically the Guotou Ruijin Healthcare Mixed A Fund (000523), which held 40,700 shares in the third quarter, accounting for 3.21% of the fund's net value, ranking as the seventh largest holding [2] - The Guotou Ruijin Healthcare Mixed A Fund (000523) was established on February 25, 2014, with a latest scale of 129 million CNY, and has achieved a year-to-date return of 33.75%, ranking 2696 out of 8154 in its category [2] - The fund manager, Liu Zexu, has been in position for 2 years and 51 days, with a total asset scale of 243 million CNY, achieving a best return of 29.7% and a worst return of 19.71% during his tenure [2]